Influenza virus: Difference between revisions
From IDWiki
(Created page with "== Background == === Microbiology === * Enveloped, single-stranded, negative-sense RNA virus in the Family::Orthomyxoviridae family * Four genera corresponding to influe...") |
No edit summary |
||
Line 1: | Line 1: | ||
== |
==Background== |
||
=== |
===Microbiology=== |
||
* |
*Enveloped, single-stranded, negative-sense RNA virus in the [[Family::Orthomyxoviridae]] family |
||
* |
*Four genera corresponding to influenza A through D |
||
* |
*Typed by hemagglutinin (HA) and neuraminidase (NA) proteins |
||
** |
**Antigenic drift refers to small mutations |
||
** |
**Antigenic shift refers to large changes from reassortment |
||
=== |
===Epidemiology=== |
||
* |
*Worldwide |
||
⚫ | |||
⚫ | |||
== Clinical Manifestations == |
|||
⚫ | |||
⚫ | |||
* Fever and respiratory symptoms, especially with myalgias |
|||
== Management == |
|||
* Neuraminidase inhibitors started within 48 hours of symptom onset are associated with a shorter duration of illness |
|||
** [[Oseltamivir]] |
|||
** [[Zanamavir]] |
|||
** [[Peramivir]] is IV only |
|||
* Monitor for secondary bacterial pneumonia |
|||
== Prevention == |
|||
* Annual influenza vaccination is recommended for everyone 6 months of age and older |
|||
* Chemoprophylaxis with [[oseltamivir]] may be indicated as post-exposure prophylaxis or during local outbreaks for all people at risk |
|||
[[Category:RNA viruses]] |
[[Category:RNA viruses]] |
Latest revision as of 13:28, 18 August 2020
Background
Microbiology
- Enveloped, single-stranded, negative-sense RNA virus in the Orthomyxoviridae family
- Four genera corresponding to influenza A through D
- Typed by hemagglutinin (HA) and neuraminidase (NA) proteins
- Antigenic drift refers to small mutations
- Antigenic shift refers to large changes from reassortment
Epidemiology
- Worldwide
- Seasonal in temperate climates, lasting from fall through spring and peaking in late winter
- Antigenic drift usually results in local outbreaks, while antigenic shift can result in epidemic or pandemics
Clinical Manifestations
- Fever and respiratory symptoms, especially with myalgias
Management
- Neuraminidase inhibitors started within 48 hours of symptom onset are associated with a shorter duration of illness
- Oseltamivir
- Zanamavir
- Peramivir is IV only
- Monitor for secondary bacterial pneumonia
Prevention
- Annual influenza vaccination is recommended for everyone 6 months of age and older
- Chemoprophylaxis with oseltamivir may be indicated as post-exposure prophylaxis or during local outbreaks for all people at risk